Transkaryotic Factor VIII gene therapy: Beth Israel Deaconess Medical Center (Boston, Mass.) resumed TKTX's 12-patient Phase I safety study, which had been susp

Transkaryotic Therapies Inc. (TKTX), Cambridge, Mass. Product: Transkaryotic Factor VIII gene therapy Business: Gene/Cell therapy Therapeutic category: Hematology Target: Clotting proteins Description...